These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 32597289)

  • 1. Effects of Teriflunomide on B Cell Subsets in MuSK-Induced Experimental Autoimmune Myasthenia Gravis and Multiple Sclerosis.
    Yilmaz V; Ulusoy C; Hajtovic S; Turkoglu R; Kurtuncu M; Tzartos J; Lazaridis K; Tuzun E
    Immunol Invest; 2021 Aug; 50(6):671-684. PubMed ID: 32597289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization with Recombinantly Expressed LRP4 Induces Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice.
    Ulusoy C; Çavuş F; Yılmaz V; Tüzün E
    Immunol Invest; 2017 Jul; 46(5):490-499. PubMed ID: 28375749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MuSK induced experimental autoimmune myasthenia gravis does not require IgG1 antibody to MuSK.
    Küçükerden M; Huda R; Tüzün E; Yılmaz A; Skriapa L; Trakas N; Strait RT; Finkelman FD; Kabadayı S; Zisimopoulou P; Tzartos S; Christadoss P
    J Neuroimmunol; 2016 Jun; 295-296():84-92. PubMed ID: 27235354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dental follicle mesenchymal stem cell administration ameliorates muscle weakness in MuSK-immunized mice.
    Ulusoy C; Zibandeh N; Yıldırım S; Trakas N; Zisimopoulou P; Küçükerden M; Tașlı H; Tzartos S; Göker K; Tüzün E; Akkoç T
    J Neuroinflammation; 2015 Dec; 12():231. PubMed ID: 26646841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silencing of FCRLB by shRNA ameliorates MuSK-induced EAMG in mice.
    Koral G; Ulusoy C; Cossins J; Lazaridis K; Türkoğlu R; Dong YY; Tüzün E; Yılmaz V
    J Neuroimmunol; 2023 Oct; 383():578195. PubMed ID: 37660538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-specific immunoadsorption of MuSK autoantibodies as a treatment of MuSK-induced experimental autoimmune myasthenia gravis.
    Lazaridis K; Baltatzidou V; Tektonidis N; Tzartos SJ
    J Neuroimmunol; 2020 Feb; 339():577136. PubMed ID: 31855721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MuSK EAMG: Immunological Characterization and Suppression by Induction of Oral Tolerance.
    Reuveni D; Aricha R; Souroujon MC; Fuchs S
    Front Immunol; 2020; 11():403. PubMed ID: 32256489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental autoimmune model of muscle-specific kinase specific myasthenia gravis in rats].
    Chen Y; Wang HB; Wang YJ
    Zhonghua Yi Xue Za Zhi; 2013 May; 93(17):1292-6. PubMed ID: 24029475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Beneficial Clinical Effects of Teriflunomide in Experimental Autoimmune Myasthenia Gravis and the Investigation of the Possible Immunological Mechanisms.
    Koseoglu E; Sungur N; Muhtaroglu S; Zararsiz G; Eken A
    Cell Mol Neurobiol; 2023 Jul; 43(5):2071-2087. PubMed ID: 36219379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injection of inactive Bordetella pertussis and complete Freund's adjuvant with Torpedo californica AChR increases the occurrence of experimental autoimmune myasthenia gravis in C57BL/6 mice.
    Maruta T; Oshima M; Mosier DR; Atassi MZ
    Autoimmunity; 2017 Aug; 50(5):293-305. PubMed ID: 28548588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferential production of IgG1, IL-4 and IL-10 in MuSK-immunized mice.
    Ulusoy C; Kim E; Tüzün E; Huda R; Yılmaz V; Poulas K; Trakas N; Skriapa L; Niarchos A; Strait RT; Finkelman FD; Turan S; Zisimopoulou P; Tzartos S; Saruhan-Direskeneli G; Christadoss P
    Clin Immunol; 2014 Apr; 151(2):155-63. PubMed ID: 24589747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscle-specific regulation of the mTOR signaling pathway in MuSK antibody seropositive (MuSK+) experimental autoimmune Myasthenia gravis (EAMG).
    Chauhan M; Punga T; Punga AR
    Neurosci Res; 2013; 77(1-2):102-9. PubMed ID: 23933211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist antibody to MuSK protects mice from MuSK myasthenia gravis.
    Oury J; Gamallo-Lana B; Santana L; Steyaert C; Vergoossen DLE; Mar AC; Vankerckhoven B; Silence K; Vanhauwaert R; Huijbers MG; Burden SJ
    Proc Natl Acad Sci U S A; 2024 Sep; 121(39):e2408324121. PubMed ID: 39288173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathogenic mechanisms of myasthenia gravis induced by antibodies against muscle-specific kinase].
    Maruyama N; Shigemoto K
    Rinsho Shinkeigaku; 2007 Nov; 47(11):842-4. PubMed ID: 18210813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular myasthenia gravis induced by human acetylcholine receptor ϵ subunit immunization in HLA DR3 transgenic mice.
    Wu X; Tuzun E; Saini SS; Wang J; Li J; Aguilera-Aguirre L; Huda R; Christadoss P
    Immunol Lett; 2015 Dec; 168(2):306-12. PubMed ID: 26493475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mouse passive-transfer model of MuSK myasthenia gravis: disrupted MuSK signaling causes synapse failure.
    Ghazanfari N; Trajanovska S; Morsch M; Liang SX; Reddel SW; Phillips WD
    Ann N Y Acad Sci; 2018 Jan; 1412(1):54-61. PubMed ID: 29125188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered agrin attenuates the severity of experimental autoimmune myasthenia gravis.
    Li Z; Li M; Wood K; Hettwer S; Muley SA; Shi FD; Liu Q; Ladha SS
    Muscle Nerve; 2018 May; 57(5):814-820. PubMed ID: 29193204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis.
    Tüzün E; Scott BG; Goluszko E; Higgs S; Christadoss P
    J Immunol; 2003 Oct; 171(7):3847-54. PubMed ID: 14500686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased bone mineral density in experimental myasthenia gravis in C57BL/6 mice.
    Oshima M; Iida-Klein A; Maruta T; Deitiker PR; Atassi MZ
    Autoimmunity; 2017 Sep; 50(6):346-353. PubMed ID: 28850269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.